Helixmith, Foreign Investors Net Buy 21,000 Shares... Stock Price Up 4.0%

Helixmith ranked among the top searched stocks for 3 days in the past month.

As of 1:31 PM on the 20th, Helixmith is trading at 31,200 KRW, up 4.0% from the previous day. This represents a 68.65% increase compared to October 30. Helixmith is known as a company specializing in new drug development focused on gene therapy.

Today, foreigners have a net purchase of 21,000 shares of Helixmith, and institutions have a net purchase of 4,000 shares, according to provisional data. Over the past 5 days, individual investors have net purchased 196,218 shares, while foreigners and institutions have net sold 223,176 shares and net purchased 31,332 shares, respectively.

On November 19, Helixmith became an issue in the market with the news of 'First dosing in Phase 3 clinical trial of gene therapy drug “上”'.

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.